Porcine circoviruses (PCV) are small nonenveloped DNA viruses containing a unique single-stranded circular genome. Previously, no recognized link was found between PCV infection of pigs and disease, and PCV was considered a nonpathogenic agent. Over the last 5 years, a ''novel'' PCV, designated PCV2, has been associated with various disease syndromes in pigs, primarily postweaning multisystemic wasting syndrome (PMWS). Pigs with PMWS have a variety of clinical signs, including debility, dyspnea, palpable lymphadenopathy, diarrhea, and pallor or icterus. Lesions associated with the presence of PCV2 in a variety of cell types include lymphohistiocytic to granulomatous interstitial pneumonia, hepatitis, nephritis, myocarditis, enteritis, and pancreatitis. The lesions of PMWS have been reproduced experimentally after inoculation of piglets with PCV2 cell culture isolates, although the full expression of the disease syndrome may require the presence of other agents such as porcine parvovirus or porcine reproductive and respiratory syndrome (PRRS) virus. Recent reports have linked PCV2 to other disorders in pigs, ranging from abortion and reproductive failure to ''atypical'' PRRS. Available data indicate high seroprevalence of antibodies to PCV2 worldwide. The diagnosis of PCV2-associated disease is based on the direct demonstration of PCV2 antigens or nucleic acid in affected tissues. PCV2 is now regarded as an important emerging pathogen. Although vertical transmission has been documented, the epidemiology of PCV2 infections is poorly understood, as is the role of the immune response in controlling or augmenting disease.
Porcine circovirus (PCV) was first described 25 years ago as a picornavirus-like contaminant of the permanent pig kidney cell culture PK/15 (ATCC-CCL 33). 55 Some 8 years later, the same workers reported PCV as a new, small, nonenveloped, icosahedral mammalian virus containing a circular single-stranded DNA genome. 50 Since this report, PCV has been assigned to the Circoviridae family, 33 and a small body of knowledge on PCV has accumulated in the scientific literature. Recently, the emergence of a new antigenically and genomically distinct PCV in the swine population worldwide, which has been directly associated with a number of clinical conditions, has raised the interest in PCVs. The proposal has been made that this new PCV should be designated PCV2 and the original PCV contaminant of PK/15 cell cultures should be designated PCV1. 8, 40 The purpose of this article is to review the current state of knowledge on PCV and provide the swine industry, veterinarians, diagnosticians, and veterinary virologists with a better understanding of PCVs. Within this article, the nomenclature PCV1 and PCV2 will be used as defined above.
Virus isolates
Replication of PCVs in vitro is best achieved by inoculation of semiconfluent monolayers of PCV-free PK/15 cells. 54 A PCV-induced cytopathic effect has not been reported, and viral replication is normally monitored by immunofluorescent or immunoperoxidase staining of infected cell cultures. 3, 54 Typically, dense nuclear staining is seen in most infected cells, with occasional large cytoplasmic inclusions in some cells ( Fig. 1 ). Care should be taken with reagents used for immunostaining of PCV-infected preparations because the pattern of staining is virtually identical to that observed with porcine parvovirus (PPV). PCV1 has been shown to replicate in other porcine-derived cell lines, 9, 50 and replication in Vero cells has been demonstrated. 3 Prolonged passage of PCV1 in Vero cells has resulted in antigenic changes in the virus, as determined by reactivity against a panel of monoclonal antibodies (MAbs) to PCV1. 3 PCV1 DNA replication has been shown to be dependent on cellular enzymes expressed during S phase of growth, and, in the natural multiplication cycle in vitro, PCV DNA replication starts only if cells have passed mitosis. 54 However, this requirement of mitosis for the onset of multiplication is greatly reduced if cells are infected and subsequently treated with a 300 mM D-glucosamine-HCl solution before they have entered the S phase after growth stimulation. 54 Treatment of inoculated cell cultures with 300 mM D-glucosamine-HCl for 30 minutes is recommended to enhance viral yields, however, care must be taken with this procedure because of the toxic nature of this preparation for cell cultures.
PCV1
PCV1 was first encountered in 1974 and reported as a picornavirus-like contaminant of the continuous pig kidney cell line PK/15. 55 A subsequent report on this suspected picornavirus-like contaminant showed that it was, in fact, a new, small, icosahedral, nonenveloped virus containing a single-stranded circular DNA genome. 50 These workers proposed the name porcine circovirus. Isolation of two PCV1 viruses from stillborn piglets has been reported. These viruses were characterized as PCV1 isolates with a panel of monoclonal and polyclonal antibodies to PCV1. 4 Isolation of a PCV-like virus from piglets with congenital tremor (type AII) has also been reported. 26 Antigenic and/or genomic characterization of this virus was not reported. Recently, PCV1 DNA from a lymph node of a piglet in France with a wasting condition has been isolated, cloned, and sequenced. 32
PCV2
In the last 3 years, a number of reports have appeared in the literature on the isolation in cell cultures of a ''novel'' PCV from diseased pigs. These new viruses have been shown to be antigenically and genomically distinct from PCV1 isolates and have been designated as PCV2 viruses. 8, 40 Antigenic distinction of these new isolates from PCV1 has been confirmed with panels of monoclonal and polyclonal antibodies. 7 PCV2-like viruses have been isolated from diseased pigs in North America, 6, 8, 19, 30, 31 Europe, [6] [7] [8] 27, 29 Taiwan (E. Clark, personal communication), and South Korea (E. Clark, personal communication).
Physicochemical and genomic organization of PCVs
PCV1 and PCV2 are small (17 nm), icosahedral, nonenveloped viruses ( Fig. 2 ) containing a singlestranded circular DNA genome. 50 The buoyant density of PCV1 in CsCl has been reported at 1.37 g/cm 3 by Tischer 55 and 1.33-1.34 g/ml by Allan et al., 9 and a sedimentation coefficient of 57 S, when compared with the known sedimentation coefficient of a bovine enterovirus, has been reported. 9 PCV1 does not hemagglutinate erythrocytes from a range of animals 48 and is resistant to inactivation after exposure to pH 3, chloroform, 56 C, and 70 C. 9 The complete nucleotide sequence (1759 nt) of the circular genome of the PCV1 contaminant of PK/15 cell cultures is known, 11, 36, 39, 43 and that PCV1 may replicate via a double-stranded replicate form (RF) by rolling circle replication has been proposed. 36, 39, 56 A PCV1 RF has been demonstrated, 49 and that both strands of the PCV1 RF are tran-scribed and encode proteins is known. 39 Seven open reading frames (ORFs) for PCV1 with the potential to encode proteins greater than 5 kD, encoded on either strand of the PCV RF, have been recognized. 34, 39 Analysis of the protein sequence encoded by ORF1 has indicated a degree of homology with the plant nanovirus ORFs known to encode replication associated proteins. 34, 39 Indeed, PCV infection in pigs may have been initiated by a plant nanovirus switching host to infect a vertebrate and then recombining with a vertebrate-infecting virus. 22 This homology with plant nanoviruses and a high amino acid sequence similarity between a potential ORF1 protein product of beak and feather disease virus and the ORF1 product of PCV1 has also been reported. 42 Recently, that the major structural protein of PCV1 is encoded for by ORF2 has been suggested. 35 Analysis of the genomes of PCV2 from isolates from North America and Europe has shown that they belong to a closely related group exhibiting a greater than 96% intragroup nucleotide sequence identity. 40 However, comparison of the genomic sequence of PCV2 isolates with the genomic sequence of PCV1 showed a Ͻ80% overall nucleotide sequence identity. 23, 40, 41 Potentially 11 ORFs, with predicted size of proteins encoded by individual ORFs from 36 to 2 kD, have been suggested for the PCV2 genome. 23 In contrast, only 6 potential ORFs in the genome of PCV2 have been identified by other workers. 40, 41 Analysis of ORF1 and ORF2 of PCV2 has shown 83% nucleotide and 86% predicted protein homology with PCV1 for ORF1 and 67% nucleotide and 65% predicted protein homology with PCV1 for ORF2, respectively. 22, 40, 41 Cterminal truncation of the PCV2 predicted proteins of ORF3 and ORF4 exists, 40, 41 and a 61.5-62% predicted amino acid identity for ORF3 of PCV2 when compared with PCV1 and a predicted amino acid identity for ORF4 of PCV2 of 83% when compared with PCV1 have been reported, 23, 40 as have a 79% and a 67% homology of 2 other ORFs of PCV2 with PCV1. 23 Little is known about the significance of the 4 smaller potential ORFs. Differentiation of PCV2 isolates by restriction enzyme analysis has been carried out. 42 The significance of this differentiation has yet to be established.
Epidemiology PCV1
Serum antibodies to PCV1 have been demonstrated in pigs in Germany, [50] [51] [52] Canada, 16 New Zealand, 28 Great Britain, 17 and Northern Ireland. 9 PCV1 infection of pigs is probably ubiquitous throughout the world. Studies on the epidemiology of PCV1 infections within pig herds have been carried out. In one study, 52 60% of sera from slaughtered pigs in Germany contained antibody titers to PCV1 as high as those found 2-6 weeks after experimental infection of pigs with the virus. From these data, the authors concluded that infection of pigs with PCV1 probably occurs in fattening units where animals are in close contact. In a more detailed study, 51 a decrease in the percentage of PCV1seronegative pigs in Germany with increasing age of the pigs, from 65% in recently weaned pigs to 5.6% for older breeder pigs, was observed. Longitudinal studies carried out on PCV1 antibody profiles in 2 litters of pigs in Northern Ireland showed that maternally derived serum antibodies to PCV1 disappeared at 8-9 weeks after birth. 9 Serum antibodies reappeared 13-15 weeks after birth, indicating exposure to the virus between 11 and 13 weeks after birth. This time scale corresponded with movement of pigs from the breeding unit to the fattening unit within the farm.
An absence of serum antibody to PCV1 in cattle, sheep, chickens, turkeys, goats, mice, rabbits, and humans has been reported. 9, 50 However, in contrast to these results, serum antibody to PCV1 has been detected in humans (30.2%), mice (12-69%), and cattle (35%) in Germany by a combination of indirect immunofluoresence and enzyme-linked immunosorbent assay (ELISA) procedures. 51 These findings have yet to be confirmed. PCV1 has been shown to infect bovine and porcine, but not ovine or human, mononuclear cells in vitro. 5 Excretion of PCV1 in feces and nasal mucus at 13 and 14 days postinfection has been demonstrated after experimental infection of seronegative day-old piglets. 52 No study has been reported on the excretion of PCV1 in naturally infected animals or on the mode of transmission of infectious virus between pigs. The isolation of a PCV-like virus from cases of congenital tremor and the reproduction of this condition by vertical transmission of the virus after experimental infection of pregnant sows has been reported. 26 This PCV-like virus remains uncharacterized. Two PCV1 viruses have been isolated from stillborn piglets, indicating that vertical transmission of this virus may occur. 4 However, in the same study, a survey of fetal tissues from pigs with reproductive problems in Northern Ireland failed to detect any evidence of fetal infection with PCV1. The possibility of vertical transmission of PCV1 requires further study. The possibility that the reported high seroprevalence of antibodies to PCV1 may have been the result of detection of cross-reactive antibodies to PCV2 has not been extensively examined. Because of a lack of specificity of the testing methods employed in previous investigations, this possibility cannot be excluded.
PCV2
To date, very little information has been published on the seroprevalence, excretion patterns, host range, or modes of transmission of PCV2. In a recent report, 14 the results of an epidemiological survey of pigs in eastern Canada indicated that serum antibody to PCV2, as determined by indirect immunofluorescence (IIF), was widespread. This survey included samples from high status specific-pathogen-free (SPF) herds, large fattening units, and small ''back yard'' herds. PCV2 serum antibody was detected in all categories of farms. In addition, as with PCV1, seroconversion of piglets to PCV2 generally occurred at 3-4 weeks postweaning. Similar results have been reported for western Canadian pigs. 24, 25 By a similar test, and a recently developed PCV2-specific ELISA, serum antibody to PCV2 has been demonstrated in pigs in France and the UK (G. Allan, unpublished data). Serum antibody to PCV2 appears to be widespread in the pig populations in countries where testing has been carried out to date. No study has been reported on excretion patterns of PCV2 in the field; however, evidence of vertical transmission of PCV2 has recently emerged. An association of PCV2 with abortions in western Canada has been documented. 57 PCV2 antigen was identified in lesions in aborted fetuses, and PCV2 was isolated from fetal tissues. Virus excretion after experimental infection of piglets with PCV2 has been reported. After experimental infection of 1-day old gnotobiotic piglets with a cell culture isolate of PCV2, viral nucleic acid was detected in feces, saliva, and eye swabs at 31 days postinoculation. This was the only time point sampled in this experiment (S. Krakowka, personal communication).
PCV-associated disease: clinical signs and lesions PCV1
Field observations. PCV1 is generally accepted to be a nonpathogenic virus. 4, 52 However, the isolation of a PCV-like virus from piglets with congenital tremor (type AII) and the experimental vertical transmission of the condition by inoculation of pregnant sows with this virus isolate have been reported. 26 This ''field'' isolate of a PCV1-like virus was not genomically or antigenically characterized, and very little detail of experimental materials and methods was included in the report.
Fetal tissues and sera from outbreaks of reproductive disorders of pigs in Northern Ireland have been examined for the presence of PCV1 antibody and/or virus. 4 In this study, no antibody to PCV1 was detected in porcine fetal sera. However, 2 isolates of PCV1 were made from stillborn piglets from a single farm. The authors concluded that the absence of antibody to PCV1 in porcine fetal sera strongly suggested that transplacental infection of porcine fetuses with PCV1 is either an extremely rare event or occurs prior to fetal immunocompetence.
Experimental observations. After experimental infection of 6 PCV antibody-negative minipigs at 9 months of age, virus was recovered from feces and nasal swabs, and all 6 minipigs seroconverted to PCV1. 52 However, none of the animals showed signs of disease. No gross or microscopic lesion was seen in these pigs after postmortem examination at 6 weeks postinoculation. In the same experiment, the authors inoculated 4 1-day-old piglets with PCV1 and again failed to demonstrate clinical disease or gross postmortem changes. The authors concluded from these results that PCV1 caused a harmless infection in pigs. 52 A similar study failed to produce clinical disease after inoculation of 2-day-old colostrum-deprived pigs with PCV1. However, the authors did demonstrate virus antigen, by immunofluorescence staining of cryostat sections, in tissues from the lymphoid system, lung, and intestine of inoculated animals. PCV1 virus predominated in the spleen (Fig. 3) , thymus (Fig. 4) , and lung and was associated with macrophage/monocyte-like cells. The authors concluded that PCV1 infections of pigs may compromise the porcine immune system. 4 This conclusion was supported by results demonstrat- ing that in vitro inoculation of porcine alveolar macrophages with PCV1 affected some immune functions of these cells. 37 In a more recent study (S. Krakowka, personal communication), 1-day-old gnotobiotic pigs experimentally infected with PCV1 failed to develop clinical disease. Aside from mild nonsuppurative myocarditis, no significant gross or histological lesions were seen in these pigs at 21 days postinfection.
PCV2
Field observations. PCV2 has been associated with a number of disease syndromes in pigs. An association of PCV with interstitial pneumonia and lymphadenopathy in a 6-week-old pig from California was reported in 1996. 15 With a generic circovirus probe, PCV DNA was detected in paraffin-embedded lung and lymph node samples by in situ hybridization. Circovirus was concluded to be the etiologic agent of the interstitial pneumonia and lymphadenopathy in the affected pig. 15 Subsequent isolation and characterization of this virus showed it to be a PCV2. 6 A wasting syndrome in Canadian pigs, first identified in 1991 in high health SPF herds in western Canada, was first reported in 1996. 13, 24 Because this syndrome was characterized by progressive loss of condition associated with lesions in several organ systems, the authors proposed the term ''postweaning multisystemic wasting syndrome'' (PMWS) to describe the clinical condition. 13, 24 PCV nucleic acid and antigen were demonstrated in abundance in the multisystemic lesions in affected pigs, and subsequent isolation and characterization of a PCV2 virus from diseased pigs was reported. 19 Also in 1996, workers in France reported a piglet wasting disease in northern France, but failed to identify a causal agent. 1 Subsequent investigations on material from affected piglets from northern France identified a PCV2 virus. 6 To date in western Canada, PMWS has been most commonly diagnosed in ''high health'' herds. These herds are typically free of the major enteric and respiratory diseases that affect swine, including mycoplasmal and actinobacillary pneumonia, atrophic rhinitis, salmonellosis, swine dysentery, transmissible gastroenteritis, and pseudorabies. Importantly, the index herd and several other herds in which PMWS has been diagnosed were porcine reproductive and respiratory syndrome virus (PRRSV)-negative. 19, 25 The affected herds have been farrow-to-finish, farrow-tofeeder, off site nursery, and grower pig operations, varying in size from very small (50 sows) to large (1,200 sows) units. Similar epidemiological information is not available for other areas of the world where PMWS has been diagnosed.
Most commonly, pigs affected with PMWS are from 5 to 12 weeks old. Common presenting clinical signs include wasting or unthriftiness, dyspnea, visibly enlarged lymph nodes, and, less frequently, pallor, diarrhea, and jaundice. 19, 24 Morbidity and mortality associated with PMWS vary, depending on the stage of the outbreak and management within affected units. In an acute outbreak, overall mortality can reach 10%, whereas morbidity and mortality in endemically infected herds are less. Individual animals can recover from PMWS, although this is poorly documented. Environmental factors such as drafts, overcrowding, poor air quality, co-mingling of age groups, and other ''stressors'' may exacerbate the severity of the disease. 25 Gross lesions in pigs with PMWS are quite variable. 13, 19, 41, 45 In the index PRRSV-negative herd, lesions in the lungs and lymph nodes were the most consistent finding (E. Clark, personal communication). Grossly, lung lesions vary from failure to collapse and increased firmness to extensive to diffuse mottling with areas of consolidation in anterior ventral areas. Histologically, there is multifocal lymphohistiocytic to diseminated granulomatous interstitial pneumonia, often with the presence of giant cells. There is often necrosis and sloughing of airway epithelium that may progress to bronchiolitis obliterans. Histological changes are associated with PCV2 antigen, found sometimes intranuclearly in epithelial cells and consistently intracytoplasmically in mononuclear phagocytes ( Fig. 5 ). Usually in affected pigs there is marked systemic lymphadenopathy, especially involving the inguinal, mesenteric, bronchial, and mediastinal lymph nodes, that are white and homogenous on cut surface. Typically, in affected lymph nodes, there is early loss of B cell follicles and expansion of paracortical (T cell) zones by infiltration of large histocytic cells and multinucleated giant cells. In early to midstages of disease, clusters of variably sized, intensely basophilic, intracytoplasmic inclusion bodies are frequently seen in B cell-dependent areas of lymphoid tissues or randomly scattered throughout the node. These changes are associated with often copious amounts of intracytoplasmic PCV2 antigen in cells of monocyte macrophage lineage, including various dendritic cells (Fig.  6 ). Similar changes are found in the spleen and Peyer's patches. Grossly, livers can be mildly icteric to markedly atrophic with prominent interlobular connective tissue. Early histological lesions comprise lymphohis-tiocytic infiltration of portal zones and single cell necrosis of hepatocytes. In ''end-stage'' hepatic disease, there is extensive swelling and vacuolation of remaining hepatocytes with karyomegaly and progressive replacement of hepatocytes by histiocytic cells. PCV2 antigen is detectable, early, intranuclearly in hepatocytes and, as the disease progresses, intracytoplasmically in Kupffer cells and infiltrating mononuclear phagocytes (Fig. 7) . Gross renal lesions vary from scattered or diffuse cortical white foci in normal sized kidneys, often with peripelvic edema, to marked enlargement and edema. Histologically, there is multifocal to diffuse lymphohistiocytic and eosinophilic infiltration of peripelvic connective tissue with edema and desmoplasia. Multifocal nonsuppurative vasculitis is a frequent finding in these areas. Cortical lesions range from multifocal tubular atrophy and regeneration to extensive tubular necrosis with edema and interstitial nephritis and fibroplasia. Usually intranuclear, PCV2 antigen is found in affected tubular epithelial cells and scattered in mononuclear phagocytes (Fig. 8 ). In the case of involvement of the gastrointestinal tract, there may be pallor, edema, and nonhemorrhagic ulceration of the pars esophagea of the stomach and fluid-filled, thin-walled intestines, especially the ileum and spiral colon. Histologically, there is villous atrophy with mild to severe, often transmural, lymphohistiocytic infiltration, with variable sloughing and/or regeneration of glandular and cryptal epithelial cells. PCV2 antigen can be found in epithelial cells in involved mucosa and in mononuclear phagocytes in the mucosa, submucosa, and lymphatics ( Fig. 9 ). Although gross lesions are uncommon in the pancreas, there may be multifocal atrophy or regeneration in acinar and ductular epithelium that is often associated with interstitial lymphohistiocytic infiltration. These changes can usually be directly associated with predominately intranuclear PCV2 antigen in acinar and ductular epithelium (Fig. 10) . The variation in organ involvement dictates collection of a wide range of tissues from several affected pigs in a group because clinically affected pigs may have severe lesions in one organ system and no lesion in others. Factors determining the variation in organ involvement are not understood but may be related to the presence of ''secondary'' infections, interisolate differences in virulence or tropism of PCV, stage of infection, or host genetics or immune response.
Since these initial reports of PCV2-related wasting disease in piglets in Canada, the USA, and Europe, PCV2-associated wasting syndromes with similar gross and histological lesions have been reported in Spain, 7, 45, 46 the United Kingdom, 29 The Republic of Ireland, 48 the USA, 30, 41 Denmark, 7 Taiwan (E. Clark, personal communication), Germany, 27 The Netherlands, Belgium, Italy, (G. Allan, unpublished data), and South Korea (E. Clark, personal communication). In all of these reports, PCV2 antigen and/or nucleic acid have been demonstrated, usually in abundance, in association with histological lesions, and, in the majority of cases, PCV2 viruses have been isolated from diseased pigs.
The extent of the involvement of PCV2 in swine diseases other than PMWS is currently poorly understood. PCV2 antigen has been demonstrated in asso- ciation with lesions in pigs with proliferating and necrotizing pneumonia (Fig. 5) , sow abortion and mortality syndrome, and dermatitis/nephropathy syndrome (E. Clark, personal communication). The suggestion has been made that infection of pigs with PCV2 or coinfection of pigs with PRRSV and PCV2 could account for the clinical conditions and lesions currently being attributed to ''atypical PRRSV'' infection. 20 Indeed, in this communication, the authors demonstrated the presence of PCV2 nucleic acid in 2 of 5 PRRSV isolates from 5 American states. 20 In a recent study, over 60% of cases diagnosed as PMWS in midwestern USA had evidence of concurrent infections with PRRSV. 47 In contrast, approximately 20% of PMWS cases in western Canada had evidence of PRRSV coinfection at necropsy. These apparently disparate results may be a reflection of PRRSV prevalence. In addition, approximately 20% of PCV2-infected western Canadian pigs with PMWS had evidence of coinfection with porcine parvovirus. 18 Coinfections of diseased pigs with PCV2 and porcine parvovirus have also been reported in Europe, 2 as have coinfections of diseased pigs with PCV2, Aujeszky's disease virus, and PRRSV. 44 Whether PCV2 is a primary immunosuppressive agent in cases of coinfection remains to be determined. In recent cases of PCV2-associated abortion in western Canada, fetuses often had variable myocardial dilatation and myocarditis associated with usually abundant PCV2 antigen in cardiac myocytes (Fig. 11 ). 57 The recently reported association of PCV2 with abortion and fetal lesions indicates that the virus should now be included in the differential diagnosis of reproductive disorders in swine.
Experimental observations. Gross and histological lesions in gnotobiotic pigs after inoculation at 3 days of age with a chloroform-treated, cell culture-grown PCV2 isolate have been reported. 21 This inoculum was later shown to contain a low titer of PPV. The lesions observed included generalized lymphadenopathy, hepatitis, nephritis, interstitial pneumonia, myocarditis, and gastritis and were described as typical of those found in field cases of PMWS. 21 In a similar study carried out on colostrum-deprived conventional piglets, 2 no clinical disease and minimal lesions were observed in pigs inoculated with PPV alone. No clinical disease, but mild to moderate lesions consistent with PMWS, was observed in pigs inoculated with PCV2 alone. Severe clinical disease and death with severe lesions, typical of PMWS, were seen in pigs inoculated with PCV2 ϩ PPV. Immunostaining of tissues from these animals revealed minimal amounts of PPV antigen in tissues, especially kidney, and large amounts of PCV2 antigen associated with lesions typical of PMWS (Fig. 12 ). However, the use of the same inocula in gnotibiotic pigs produced mild or no lesions in pigs inoculated with PCV2 alone but did produce severe clinical disease and lesions typical of PMWS after inoculation of pigs with PCV2 ϩ PPV (S. Krakowka, personal communication). The authors concluded from these results that exposure of piglets to undefined environmental factors and/or infectious agents that facilitate stimulation of the piglets' immune system may be necessary, in conjunction with exposure to PCV2, to produce clinical disease.
A recent report documented reproduction of lesions typical of PMWS in 8-week-old conventionally reared pigs that were inoculated with PCV2-containing tissue homongenates derived from field cases of PMWS. No or mild clinical sign was seen in animals with lesions.
In these experiments, the involvement of other infectious agents, in addition to PCV2, was not completely ruled out. 10 Additional studies are required to better understand the pathogenesis of PCV2-associated diseases, particularly with regard to identifying infectious and noninfectious cofactors, and determining the early events in PCV2 infection, including primary target cells in vivo.
Diagnosis
Currently, the demonstration of serum antibody to PCV1 or PCV2 in pigs can be achieved by an IIF or indirect immunoperoxidase (IIP) test. 6, 19 Care must be taken in interpretation of the results of these tests because a slight degree of antigenic cross-reactivity between PCV1 and PCV2 isolates has been demonstrated. 6 The authors recommend testing sera at 1/10, 1/ 100, and 1/1000 dilutions to ease interpretation of re-sults. A PCV2-specific antibody-detection ELISA has recently been developed and is now available for large serological surveys (G. Allan and J. Ellis, unpublished data). However, detection of serum antibody to PCV1 or PCV2 in pigs does not appear, in itself, to be indicative of an existing or potential disease problem.
The definitive diagnosis of a PCV-related disease is based on the detection of viral antigen and/or nucleic acid associated with lesions in diseased pigs. The ongoing emergence of a number of clinical conditions and syndromes in pigs that have now been associated with PCV2 infection, in conjunction with the possibility that previously diagnosed cases of PRRS may, in fact, involve coinfection with PCV2, 20 suggests that, when possible, PCV2 infection should be considered in porcine cases, regardless of the presumptive diagnosis obtained from clinical examination.
PCV1-and PCV2-specific MAbs have been produced, 3, 7 and these can be used for immunostaining of acetone-fixed tissue impression smears, cryostat sections, formalin-fixed, paraffin-embedded tissues, or inoculated cell cultures (S. Kennedy, personal communication). 3 Immunostaining and in situ hybridization assays have been described for detection of PCV in tissues from field cases of wasting disease 12, 19, 30, 41, 45 and reproductive disorders. 57 A comparison of in situ hybridization and immunocytochemistry techniques for the detection of PCV2 in long-term, formalin-fixed, paraffin-embedded tissues from experimental and field disease has shown immunocytochemistry to be more sensitive than in situ hybridization. 38 However, in this study, the hybridization probes used were based on the PCV1 whole genomic sequence. In view of the significant genomic differences now known to exist between PCV1 and PCV2 isolates, probes for detection of PCV2 should not be modeled on the PCV1 genomic sequence. Three to four times greater sensitivity with in situ hybridization for the detection of PCV2 nucleic acid has been demonstrated with an antisense strand probe when compared with a sense strand probe. 41 MAbs have also been used to develop a PCV2-specific antigen-capture ELISA that is currently being assessed (G. Allan and J. Ellis, unpublished data). Differential polymerase chain reaction (PCR) tests have been described for the detection of PCV1 and PCV2 and the diagnosis of PCV-related diseases. 7, 23, 31, 42 However, the use of this test for diagnosis of PCV-related diseases can be problematic. The unique sensitivity of the PCR is ideal for the detection of minimal amounts of viral nucleic acid in tissue samples. However, this unique sensitivity can, in itself, be an inherent problem. PCV1 is endemic in pig populations throughout the world, and evidence to date suggests that PCV2 infection of pigs can occur without progression to disease. The possibility also exists that PCV may inte-grate into host genome. 53 In addition, although great care can be taken in laboratories dedicated to PCR diagnostics to avoid cross contamination, the possibility of contamination of tissue samples with PCV at necropsy on farms or in postmortem facilities is more difficult to control. Under these circumstances, the demonstration of a PCV PCR product from tissues from diseased pigs does not necessarily equate with a PCV-related disease. The emergence and application of quantitative PCR technology to diagnostics may, in the future, go some way to alleviating the problems outlined above with the application of current diagnostic PCR to endemic agents.
Definitive diagnosis of PCV2-associated diseases can be obtained only by demonstration of PCV2 nucleic acid and/or antigen associated with lesions. Currently, no generally accepted ''case definition'' exists for PMWS. However, the presence of characteristic PCV2-containing lesions in 1 or more organ systems together with the history and typical clinical signs, usually involving debilitation, are compatible with a diagnosis of PMWS as originally described. 24
Control
Currently very little is known about control of PCVrelated diseases. PCVs are highly resistant to inactivation by common detergents and disinfectants, making decontamination of infected premises difficult, if not impossible. No vaccine to PCVs is available at present. Of particular interest to note is that the initial outbreaks of PCV2-related PMWS in Canada primarily occurred in high status SPF herds where biosecurity was well maintained. 19, 24, 25 Apparently, good biosecurity, although always to be recommended, does not assure freedom from PCV2-associated disease. Rapid and accurate diagnosis and removal of diseased animals from farms, combined with good husbandry practices, would appear to be the only current method of controlling losses attributable to PCV2 infections.
Conclusions
PCVs are relatively newly discovered viruses. Until recently, no definitive link between PCV infection of pigs and disease had been proved and PCV was considered a nonpathogenic virus. The emergence over the last 5 years of a ''novel'' PCV, designated PCV2, and the strong association of this virus with various disease syndromes in pigs, primarily PMWS, have changed this concept, and PCV2 is now regarded as an important emerging pathogen. Recent reports have linked PCV2 to a range of disorders in pigs, including ''atypical'' PRRS, and PMWS has been reproduced experimentally after infection of piglets with PCV2 cell culture isolates. Additional studies into the epidemiology and immunology of PCV infections are now required if better understanding and eventual control of the disease syndromes associated with these viruses are to be achieved.
